Search - tctmd.com

Displaying 101 - 120 of 228

Presentation TCT 2018

Case #1: Severe LVOT Obstruction in a Symptomatic 20-Year Old Male Despite Maximized Medical Treatment

Presenter: Sherif F. Nagueh, Hubert Seggewiss, John S. Douglas Jr, Valerian Fernandes, Vijay Iyer, Srihari S. Naidu, Nish Patel, Alexandre C. Zago

September 24, 2018

Presentation TCT 2018

Introduction: What Do We Hope to Learn From these Cases?

Presenter: Sherif F. Nagueh, Hubert Seggewiss

September 24, 2018

News Opinion Editor's Corner TCT 2018

TCT 2018, Day Two: COAPT Prompts Round of Applause, Plus New Valve Insights

Shelley Wood

September 23, 2018

Presentation TCT 2018

Constrictive Pericarditis or Restrictive Cardiomyopathy Hemodynamic Old School

Presenter: Morton J. Kern, Holger Thiele, Gerhard C. Schuler

September 23, 2018

News Daily News TCT 2018

High Mortality but Durable Results With Valve-in-Valve TAVR

Michael O'Riordan

September 23, 2018

Presentation TCT 2018

Hypertrophic Cardiomyopathy - Brockenbrough Phenomenon and More

Presenter: Morton J. Kern, Holger Thiele, Joseph P. Carrozza Jr

September 23, 2018

Presentation TCT 2017

Preliminary Results of Hybrid, Less-Invasive Left Ventricular Reshaping for Ischemic Cardiomyopathy the St. Antonius Hospital Experience

Presenter: Daniel Burkhoff, Samir R. Kapadia, Patrick Klein

November 01, 2017

Presentation TCT 2017

TAVR for Severe AS and Hypertrophic Cardiomyopathy

Presenter: Gregory P. Fontana, Amar Krishnaswamy

November 01, 2017

Presentation TCT 2017

TCT 103: Long-Term Outcomes of Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: A 16 Year Study

Presenter: Brij Maini, Petr Neuzil, Christopher Capps, MD

October 31, 2017

Presentation TCT 2017

Transcatheter Left Ventricular Reconstruction for Treatment of Post-Myocardial Infarction Ischemic Cardiomyopathy

Presenter: Vasilis Babaliaros, Shmuel Banai, Andrew Wechsler

October 30, 2017

Presentation TCT 2017

Does Left Ventricular Hypertrophy Compromise Coronary Flow Reserve and Affect Intervention Choices?

Presenter: Mark C. Bates, Bernard J. Gersh, Justin E. Davies

October 30, 2017

Presentation TCT 2017

Getting Surgical-like Results With Alcohol Septal Ablation

Presenter: Carey D. Kimmelstiel, Richard Smalling, Paul Sorajja

October 30, 2017

Presentation TCT 2017

Alcohol Septal Ablation - Learning Techniques Through Proctoring

Presenter: Carey D. Kimmelstiel, Richard Smalling, Srihari S. Naidu

October 30, 2017

Presentation TCT 2017

Building an HCM Program - Benchmarks for Centers of Excellence

Presenter: Carey D. Kimmelstiel, Richard Smalling, Sherif F. Nagueh

October 30, 2017

Presentation TCT 2017

Can Alcohol Ablation Be Used to Treat Ventricular Tachycardia?

Presenter: John S. Douglas Jr, Valerian Fernandes, Vivek Y. Reddy

October 30, 2017

Presentation TCT 2017

High-grade AV Block After ASA

Presenter: John S. Douglas Jr, Valerian Fernandes

October 30, 2017

Presentation TCT 2017

Might Mitraclip Make Ablation Irrelevant?

Presenter: John S. Douglas Jr, Valerian Fernandes, Paul Sorajja

October 30, 2017

Presentation TCT 2017

Evaluation and Management of AS With Obstructive HCM

Presenter: John S. Douglas Jr, Valerian Fernandes, Srihari S. Naidu

October 30, 2017

Presentation TCT 2017

When to Declare Victory

Presenter: John S. Douglas Jr, Valerian Fernandes, Christopher D. Nielsen

October 30, 2017

Presentation TCT 2017

My Worst Complication(s)

Presenter: John S. Douglas Jr, Valerian Fernandes, George S. Hanzel

October 30, 2017

Advertisement

Case #1: Severe LVOT Obstruction in a Symptomatic 20-Year Old Male Despite Maximized Medical Treatment

Introduction: What Do We Hope to Learn From these Cases?

TCT 2018, Day Two: COAPT Prompts Round of Applause, Plus New Valve Insights

Constrictive Pericarditis or Restrictive Cardiomyopathy Hemodynamic Old School

High Mortality but Durable Results With Valve-in-Valve TAVR

Hypertrophic Cardiomyopathy - Brockenbrough Phenomenon and More

Preliminary Results of Hybrid, Less-Invasive Left Ventricular Reshaping for Ischemic Cardiomyopathy the St. Antonius Hospital Experience

TAVR for Severe AS and Hypertrophic Cardiomyopathy

TCT 103: Long-Term Outcomes of Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: A 16 Year Study

Transcatheter Left Ventricular Reconstruction for Treatment of Post-Myocardial Infarction Ischemic Cardiomyopathy

Does Left Ventricular Hypertrophy Compromise Coronary Flow Reserve and Affect Intervention Choices?

Getting Surgical-like Results With Alcohol Septal Ablation

Alcohol Septal Ablation - Learning Techniques Through Proctoring

Building an HCM Program - Benchmarks for Centers of Excellence

Can Alcohol Ablation Be Used to Treat Ventricular Tachycardia?

High-grade AV Block After ASA

Might Mitraclip Make Ablation Irrelevant?

Evaluation and Management of AS With Obstructive HCM

When to Declare Victory

My Worst Complication(s)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content